SCHEDULE: Strata Critical Medical Investor Boosts Stake

Velibor Krstic has increased his beneficial ownership of Strata Critical Medical warrants to 12.4%, citing undervaluation and strategic investment goals.

Summary

• Velibor Krstic, a private investor, has acquired a significant stake in Strata Critical Medical, Inc., now beneficially owning 1,139,393 warrants, representing 12.4% of the outstanding public warrants.
• The total purchase price for these warrants over the past 60 days was approximately $19,380, with the most recent acquisition of 374,958 warrants on April 8, 2026, for an average price of $0.011 per warrant.
• Krstic also holds 26,425 shares of Strata Critical Medical's Common Stock, acquired on July 10, 2024.
• The investor believes the current market price of the warrants is undervalued, especially considering the company's Adjusted EBITDA of $14.1 million and the successful integration of Keystone Perfusion.
• Krstic intends to actively monitor the company's board and management decisions and may engage in discussions with the Issuer and KSL Capital Partners regarding options to maximize investment value, potentially including a voluntary Exchange Offer or an amendment to the Warrant Agreement.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as moderately positive due to the investor's stated confidence in the company's fundamentals and strategic potential, balanced by the potential for future strategic maneuvers that could introduce uncertainty.

Positives

• Significant increase in beneficial ownership of warrants by an investor, indicating confidence.
• Investor cites positive company fundamentals, including an Adjusted EBITDA of $14.1 million.
• Successful integration of Keystone Perfusion is noted as a positive development.
• Long-term ownership of common stock demonstrates commitment to the company.
• Investor's stated intention to maximize value aligns with stakeholder interests.

Negatives

• The purchase price for the warrants was very low, suggesting a distressed valuation or high risk associated with the warrants.
• The investor's active monitoring and potential engagement with management and the sponsor could signal dissatisfaction or a desire for significant strategic changes.

Risks

• The investor's potential engagement in discussions for a voluntary Exchange Offer or amendment to the Warrant Agreement could lead to uncertainty or changes in the terms of existing warrants.
• Active monitoring of board and management decisions by a significant warrant holder could indicate potential governance concerns or pressure for strategic shifts.

Future Outlook

The investor intends to actively monitor the company's board and management decisions leading up to the warrant expiration date and may engage in discussions to maximize investment value, potentially including a voluntary Exchange Offer or an amendment to the Warrant Agreement.

Industry Context

StockSavvy.ai notes that significant warrant holder activity, especially when coupled with commentary on undervaluation and potential strategic actions, often precedes corporate actions aimed at unlocking shareholder value or restructuring existing agreements. The mention of Adjusted EBITDA and integration success points to operational focus within the critical medical sector.

Stakeholder Impact

• Shareholders may see potential value enhancement if the investor's proposed actions lead to improved company performance or strategic restructuring.
• Other warrant holders could be impacted by potential amendments to the Warrant Agreement or an Exchange Offer.
• The Sponsor (KSL Capital Partners) may be involved in discussions regarding strategic options.

Next Steps

• Velibor Krstic will actively monitor the decisions of the Board of Directors and management.
• Potential discussions with Strata Critical Medical, the Sponsor (KSL Capital Partners), and other shareholders regarding options to maximize investment value.
• Possible implementation of a voluntary Exchange Offer or an amendment to the Warrant Agreement.

Key Dates

Recommendation

The filing indicates a significant investment in warrants by an individual investor who believes the company is undervalued. However, the potential for strategic discussions and changes to warrant agreements introduces a degree of uncertainty. A 'hold' recommendation is appropriate as it allows investors to observe the outcomes of the investor's engagement and any subsequent strategic shifts before making a more definitive decision.

Keywords

Strata Critical Medical, Schedule 13D, Warrants, Velibor Krstic, Investment, Beneficial Ownership, SEC Filing, Adjusted EBITDA, Keystone Perfusion, KSL Capital Partners